Publications
Now that the patent has expired, this cancer drug is suddenly 99% cheaper
The patent on the cancer drug Revlimid (lenalidomide) recently expired. Whereas a few weeks ago a pack still cost over 4,500 euros, after generic comp
Amsterdam Medical Center creates ‘hijacked’ medicine
Using a set of legal tricks, the pharmaceutical industry was able to turn an animal gallic acid into a medicine that costs tons of money per year. Res
The outrageous pricing model used by Big Pharma
Pharmaceutical firm Novartis charges €2 million for a single intravenous infusion — but the National Health Care Institute in the Netherlands declared
Brussels pressured drug regulator to approve Pfizer vaccine
Leaked documents show that the European Commission put pressure on the European Medicines Agency to approve the first Covid-19 vaccines simultaneously
‘As long as it is for free’
Most of the demand for (refresher) training courses for doctors in the Netherlands is fulfilled by industry- sponsored programmes. Even after decades
From blockbuster to nichebuster
Two decades of EU market protection of ‘orphan’ (rare disease) medicines have greatly benefitted the industry. According to research by The Investigat
Evergreening the world’s most profitable medicine
Even after the expiration of Humira’s patent protection, pharmaceutical company AbbVie almost completely fended off biosimilar competition for this bl
Reconstruction lutetium octreotate
Steve Jobs’ private plane, parked at Rotterdam Airport. It is September 2008 when local reporters receive tips about the arrival of Apple’s CEO in the
